WATERTOWN, Mass., Oct. 24, 2025 /PRNewswire/ — Orna Therapeutics, a leading biotechnology company developing a proprietary pipeline of in vivo therapies across a broad range of autoimmune and oncology indications, today announced an upcoming presentation at the American College of Rheumatology (ACR) Annual Meeting being held October 24-29, 2025, in Chicago, Illinois. This dataset is a broader… Continue reading Orna Therapeutics Announces Encore Presentation at the American College of Rheumatology Annual Meeting Supporting its in vivo CAR Therapy Approach in Autoimmune Diseases
Tag: Manufacturing
AAM to Announce Third Quarter Financial Results on November 7
DETROIT, Oct. 24, 2025 /PRNewswire/ — American Axle & Manufacturing Holdings, Inc. (AAM), (NYSE: AXL) will hold a conference call to discuss third quarter financial results and other related matters at 10:00 a.m. ET on Friday, November 7, 2025. A press release announcing the results will be issued before the market opens on the same… Continue reading AAM to Announce Third Quarter Financial Results on November 7
ChemDiv Extends Discovery and Early Development Partnership with Mondego Bio on Best-in-Class PTPN2 Immuno-Oncology Program
SAN DIEGO, Oct. 24, 2025 /PRNewswire/ — ChemDiv today announced the extension of its discovery and early development partnership with Mondego Bio to advance the company’s best-in-class immuno-oncology program targeting PTPN2. The announcement follows Mondego Bio’s successful Series A financing led by Biovance Capital with participation from OrbiMed Advisors and Torrey Pines Investment, underscoring strong… Continue reading ChemDiv Extends Discovery and Early Development Partnership with Mondego Bio on Best-in-Class PTPN2 Immuno-Oncology Program
Car production slumps to a 73-year low after JLR cyber-attack
Car output dropped to 51,100, from 70,000 in September 2024. Photograph: Matt Crossick/Alamy View image in fullscreen Car output dropped to 51,100, from 70,000 in September 2024. Photograph: Matt Crossick/Alamy Car production slumps to a 73-year low after JLR cyber-attack Shutdown contributes to 27% slump across the UK sector, which says it remains under ‘immense… Continue reading Car production slumps to a 73-year low after JLR cyber-attack
Calumet, Inc. to Release Third Quarter 2025 Earnings on November 7, 2025
INDIANAPOLIS, Oct. 24, 2025 /PRNewswire/ — Calumet, Inc. (NASDAQ: CLMT) (the “Company,” “Calumet,” “we,” “our” or “us”), announced today that it plans to report results for the Third Quarter 2025 on November 7, 2025. A conference call to discuss the financial and operational results is scheduled for November 7th at 9:00 AM ET. Investors, analysts and members of… Continue reading Calumet, Inc. to Release Third Quarter 2025 Earnings on November 7, 2025
Origin Agritech Obtains New Licenses for Crop Seed Production and GMO Business Operations
Strategic Restructuring Positions Company to Strengthen Market Presence with Expanded Operational Capabilities BEIJING, Oct. 24, 2025 /PRNewswire/ — Origin Agritech Ltd. (NASDAQ: SEED) (“Origin” or the “Company”), a leading Chinese agricultural technology company, today announced a series of major milestones designed to enhance its operational capabilities, strengthen its market position, and advance its long-term growth strategy.… Continue reading Origin Agritech Obtains New Licenses for Crop Seed Production and GMO Business Operations
Lilly’s EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
New long-term extension data show approximately 80% of patients achieved or maintained meaningful skin improvement (EASI 75) with EBGLYSS with half the doses compared to approved monthly maintenance dosing Lilly submitted these data to the FDA for a potential label update for EBGLYSS If approved, EBGLYSS would be a first-line biologic that offers the option… Continue reading Lilly’s EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
Shanghai Electric Signs Parau Phase II 342 MW PV Project with Econergy, Supporting Romania’s Green Future
As Shanghai Electric’s fourth photovoltaic project in Romania, this initiative marks a major step forward for the country’s clean energy sector. SHANGHAI, Oct. 24, 2025 /PRNewswire/ — Shanghai Electric (SEHK: 2727, SSE: 601727) celebrated a major milestone on October 1 with the signing of the second phase of the 342 MW photovoltaic (PV) general contracting project… Continue reading Shanghai Electric Signs Parau Phase II 342 MW PV Project with Econergy, Supporting Romania’s Green Future
Trilogy Metals Provides Update on the Issuance of Federal Right-of-Way Permits for the Ambler Access Project in Alaska
VANCOUVER, BC, Oct. 24, 2025 /PRNewswire/ – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) (“Trilogy” or the “Company”) is providing an update on the Ambler Access Project (“AAP” or “Ambler Access Road”) – the proposed 211-mile, industrial-use-only road from the Upper Kobuk Mineral Projects (“UKMP”) to the Dalton Highway that would enable the advancement… Continue reading Trilogy Metals Provides Update on the Issuance of Federal Right-of-Way Permits for the Ambler Access Project in Alaska
Yuchai Launches New Generation High-Horsepower YC16VTF Generator Engine
SINGAPORE, Oct. 24, 2025 /PRNewswire/ — China Yuchai International Limited (NYSE: CYD) (“China Yuchai” or the “Company”), one of the largest powertrain solution manufacturers through its main operating subsidiary in China, Guangxi Yuchai Machinery Company Limited (“Yuchai”), announced that its subsidiary Yuchai Marine and Genset Power Company Limited successfully launched its new YC16VTF engine at… Continue reading Yuchai Launches New Generation High-Horsepower YC16VTF Generator Engine